| Literature DB >> 27356917 |
Rodrigo Binkowski de Andrade1,2,3, Tanise Gemelli4, Denise Bertin Rojas4, Tomas Duk Hwa Kim5, Ângela Zanatta4, Felipe Schmitz4, André Felipe Rodrigues4, Angela T S Wyse4,5, Moacir Wajner4,5, Carlos Severo Dutra-Filho4,5, Clovis Milton Duval Wannmacher4,5.
Abstract
Sarcosine is an N-methyl derivative of the amino acid glycine, and its elevation in tissues and physiological fluids of patients with sarcosinemia could reflect a deficient pool size of activated 1-carbon units. Sarcosinemia is a rare inherited metabolic condition associated with mental retardation. In the present study, we investigated the acute effect of sarcosine and/or creatine plus pyruvate on some parameters of oxidative stress and energy metabolism in cerebral cortex homogenates of 21-day-old Wistar rats. Acute administration of sarcosine induced oxidative stress and diminished the activities of adenylate kinase, GAPDH, complex IV, and mitochondrial and cytosolic creatine kinase. On the other hand, succinate dehydrogenase activity was enhanced in cerebral cortex of rats. Moreover, total sulfhydryl content was significantly diminished, while DCFH oxidation, TBARS content, and activities of SOD and GPx were significantly enhanced by acute administration of sarcosine. Co-administration of creatine plus pyruvate was effective in the prevention of alterations provoked by sarcosine administration on the oxidative stress and the enzymes of phosphoryltransfer network. These results indicate that acute administration of sarcosine may stimulate oxidative stress and alter the energy metabolism in cerebral cortex of rats. In case these effects also occur in humans, they may contribute, along with other mechanisms, to the neurological dysfunction of sarcosinemia, and creatine and pyruvate supplementation could be beneficial to the patients.Entities:
Keywords: Cerebral cortex; Energy metabolism; Oxidative stress; Sarcosine; Sarcosinemia
Mesh:
Substances:
Year: 2016 PMID: 27356917 DOI: 10.1007/s12035-016-9984-1
Source DB: PubMed Journal: Mol Neurobiol ISSN: 0893-7648 Impact factor: 5.590